| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.7 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |